Citation Impact
Citing Papers
Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
2017 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Comparative Risk for Harms of Second-Generation Antidepressants
2008
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
2011
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder
2010 Standout
Modulation of cardiac autonomic functions in patients with major depression treated with repetitive transcranial magnetic stimulation
2007
Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation
2005
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach
2016
Cognition and Depression: Current Status and Future Directions
2010 Standout
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder
2011
Depression
2018 Standout
Major depressive disorder
2016 Standout
Opposite effects of high and low frequency rTMS on mood in depressed patients: Relationship to baseline cerebral activity on PET
2008
Exercise Fails to Improve Neurocognition in Depressed Middle-Aged and Older Adults
2008
Antidepressant Effects of High and Low Frequency Repetitive Transcranial Magnetic Stimulation to the Dorsolateral Prefrontal Cortex
2007
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
A meta-analysis of depression severity and cognitive function
2009
The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis
2007
Should We Expand the Toolbox of Psychiatric Treatment Methods to Include Repetitive Transcranial Magnetic Stimulation (rTMS)?
2010 Standout
Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate
2012 Standout
Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis
2008
Psychedelics
2016 Standout
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
2006
Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression
2009
The pharmacology of putative early-onset antidepressant strategies
2003
Psychiatric Pharmacogenomics in Pediatric Psychopharmacology
2012
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation
2007
Aerobic Exercise and Neurocognitive Performance: A Meta-Analytic Review of Randomized Controlled Trials
2010 Standout
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
Gene–environment interaction analysis of serotonin system markers with adolescent depression
2004
Pharmacogenetics of Antidepressants
2011
Depression in adolescence
2012 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala
2005
Major Depressive Disorder
2008 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression
2007
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test
2005
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Serotonin and decision making processes
2011
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders
2002
Effects of the South American Psychoactive Beverage <i>Ayahuasca </i>on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography
2004
Transcranial Magnetic Stimulation: A Primer
2007 Standout
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes
2002
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Molecular biomarkers of depression
2016
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review
2009
Industry sponsorship and research outcome
2012 Standout
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
2008
Prevalence and management of treatment-resistant depression.
2007
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Transcranial magnetic stimulation
2009
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Dopamine D2-Like Receptors and the Antidepressant Response
2006
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
Duloxetine versus other anti-depressive agents for depression
2012
Industry sponsorship and research outcome
2017 Standout
Works of David Rossini being referenced
Transcranial magnetic stimulation in treatment-resistant depressed patients: A double-blind, placebo-controlled trial
2005
Antidepressant response in the elderly
2007
Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial
2005
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients
2009
Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression
2001
Sertraline Versus Fluvoxamine in the Treatment of Elderly Patients With Major Depression
2005
Comparison of Response to Fluvoxamine in Nondemented Elderly Compared to Younger Patients Affected by Major Depression
2003
No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors
2001
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity
2002
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders
2004
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
2001
Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder
2004
Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?
2000
Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: An exploratory analysis
2006